Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
57.79
+0.72 (1.26%)
Nov 21, 2024, 11:48 AM EST - Market open
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $9.72 billion as of November 21, 2024. Its market cap has increased by 312.88% in one year.
Market Cap
9.72B
Enterprise Value
8.14B
1-Year Change
312.88%
Ranking
Category
Stock Price
$57.79
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $9.72B, an increase of 491.15%. That is a compound annual growth rate of 45.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 9.60B | 103.41% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 59.81% |
| Feb 13, 2020 | 1.64B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Charles River Laboratories International | 9.59B |
| Medpace Holdings | 9.58B |
| Penumbra | 9.23B |
| Henry Schein | 9.21B |
| Exact Sciences | 9.17B |
| Qiagen | 9.11B |
| Bio-Rad Laboratories | 9.04B |
| Teleflex | 9.03B |